Bioelectronic 448 kHz Radiofrequency Stimulation Proposed to Restore Thymic Immune Tolerance in Type 1 Diabetes

Type 1 Diabetes Mellitus (T1DM) arises from a fundamental breakdown of central immune tolerance within the thymus. Medullary thymic epithelial cells (mTECs) express the Autoimmune Regulator (AIRE) protein, which drives the promiscuous transcription of peripheral tissue-restricted antigens—including insulin—creating a

This paper hypothesizes that the thymic microenvironment can be bioelectronically reprogrammed to re-establish central immune tolerance in T1DM. The proposed strategy involves non-invasive application of 448 kHz radiofrequency (RF) fields, delivered via a wearable smart patch using subthermal Capacitive-Resistive Electric Transfer (CRET). This stimulation is hypothesized to selectively upregulate AIRE-dependent insulin expression in mTECs, thereby restoring the intrathymic "immunological shadow" of the pancreatic β-cell.

The 448 kHz RF field is hypothesized to interact with L-type voltage-gated calcium channels (Cav1.2/Cav1.3) on mTEC membranes, inducing a controlled, subthermal Ca²+ influx. This calcium signal is proposed to activate two parallel intracellular cascades: the MAPK/ERK pathway and the calcineurin/NFAT-NF-κB axis. Both pathways are predicted to converge on transcriptional upregulation of AIRE and, consequently, enhanced intrathymic insulin (Ins2) expression.

Strengthened negative selection and the preferential generation of epigenetically stable Helios+Foxp3+ thymus-derived regulatory T-cells (tTregs) are predicted as downstream immunological outcomes.